ArticleJournal of diabetes research2026
Preservation of Nociceptor Intraepidermal Nerve Fibres in Diabetic Neuropathic Pain.
Article in Journal of diabetes research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Peripheral painful sensory neuropathy represents a prevalent and disabling complication of Type 1 and Type 2 diabetes. Unfortunately, despite the clinical need for improved analgesic approaches, clinicians remain inadequately provisioned to treat these patients as many analgesics are ineffective or initiate undesirable health-impacting side effects. During diabetes, the viability of the peripheral sensory nervous system is vulnerable, depicted by sensory neurodegeneration and neuropathic pain. However, it remains undefined how nociceptor intraepidermal fibre innervations are affected in patients and rodent models. Here, rodent models of chemically induced Type 1 and dietary induced prediabetes/Type 2 diabetic peripheral sensory neuropathy were utilised to investigate the impact upon nociceptor degeneration in painful diabetic neuropathy. Streptozotocin-induced Type 1 diabetes as well as 42% and 60% high-fat diets caused mechanical allodynia when compared with age-matched controls. Furthermore, dietary interventions led to a sustained hypersensitivity to thermal stimuli and a transient mechanical allodynia that was observed in the early phase, which later resolved. Histological analysis of plantar skin of the hind limbs demonstrated a significant reduction in total intraepidermal nerve fibre (IENF) density (PGP9.5 labelled), indicating sensory neurodegeneration in Type 1 and prediabetes/Type 2 diabetic rodent models. However, CGRP-positive nociceptor IENFs remain preserved, pointing to differential vulnerability among sensory fibre subtypes. Additionally, in Type 1, there was an increased presence of Langerhan cells, whereas this was not presented in the dietary induced models. This provides mechanistic insight into painful diabetic neuropathy and provides fundamental understanding that will support improved treatment of diabetic sensory neuropathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.